@GoldenEaglev2 'It is also a perfect testing ground for new genetics in a production setting. Can't do that at Northern because it's a shit box from like four decades ago.' What does this even mean?
'The other company I was looking at was IHL. They have 3 or more clinical trials at either phase 2 or phase 1, but they are collaborating with the FDA and their formulations are more complex than simple low-dose CBD' You do realize we aren't even looking at using Satipharm in US markets at the moment and that the OTC scheme is for low-dose CBD products.
